Sun, W., Ge, Y., Cui, J., Yu, Y., & Liu, B. (2021). Scutellarin resensitizes oxaliplatin-resistant colorectal cancer cells to oxaliplatin treatment through inhibition of PKM2. Mol Ther Oncolytics.
Chicago Style CitationSun, Wei, Yang Ge, Junpeng Cui, Yifan Yu, i Baolin Liu. "Scutellarin Resensitizes Oxaliplatin-resistant Colorectal Cancer Cells to Oxaliplatin Treatment Through Inhibition of PKM2." Mol Ther Oncolytics 2021.
Cita MLASun, Wei, et al. "Scutellarin Resensitizes Oxaliplatin-resistant Colorectal Cancer Cells to Oxaliplatin Treatment Through Inhibition of PKM2." Mol Ther Oncolytics 2021.
Atenció: Aquestes cites poden no estar 100% correctes.